126 related articles for article (PubMed ID: 32649319)
1. Recent Trends and Overall Survival of Young Versus Older Adults With Stage II to III Rectal Cancer Treated With and Without Surgery in the United States, 2010-2015.
Sanford NN; Dee EC; Ahn C; Kazmi SA; Beg MS; Folkert MR; Aguilera TA; Polanco PM; Pogacnik JS; Sher DJ
Am J Clin Oncol; 2020 Oct; 43(10):694-700. PubMed ID: 32649319
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994-2009.
Cho MM; Morgan JW; Knutsen R; Oda K; Shavlik D; Knutsen S; Kazanjian K
Dis Colon Rectum; 2013 Dec; 56(12):1357-65. PubMed ID: 24201389
[TBL] [Abstract][Full Text] [Related]
3. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
4. National Trends in Nonoperative Management of Rectal Adenocarcinoma.
Ellis CT; Samuel CA; Stitzenberg KB
J Clin Oncol; 2016 May; 34(14):1644-51. PubMed ID: 27022115
[TBL] [Abstract][Full Text] [Related]
5. Current trends in nonoperative management for rectal adenocarcinoma: An unequal playing field?
Lee KC; Zhao B; Pianka K; Liu S; Eisenstein S; Ramamoorthy S; Lopez NE
J Surg Oncol; 2022 Dec; 126(8):1504-1511. PubMed ID: 36056914
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
7. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
8. Ten-year survival after pathologic complete response in rectal adenocarcinoma.
Sell NM; Qwaider YZ; Goldstone RN; Cauley CE; Cusack JC; Ricciardi R; Bordeianou LG; Berger DL; Kunitake H
J Surg Oncol; 2021 Jan; 123(1):293-298. PubMed ID: 33022797
[TBL] [Abstract][Full Text] [Related]
9. Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.
Margalit O; Mamtani R; Kopetz S; Yang YX; Lawrence YR; Abu-Gazala S; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
Oncologist; 2019 Aug; 24(8):e671-e676. PubMed ID: 30696723
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer.
Jiang DM; Raissouni S; Mercer J; Kumar A; Goodwin R; Heng DY; Tang PA; Doll C; MacLean A; Powell E; Price-Hiller J; Monzon J; Cheung WY; Vickers MM
Ann Oncol; 2015 Oct; 26(10):2102-6. PubMed ID: 26232491
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
Karagkounis G; Thai L; Mace AG; Wiland H; Pai RK; Steele SR; Church JM; Kalady MF
Ann Surg; 2019 Jun; 269(6):1117-1123. PubMed ID: 31082910
[TBL] [Abstract][Full Text] [Related]
12. Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study.
Araujo RO; Valadão M; Borges D; Linhares E; de Jesus JP; Ferreira CG; Victorino AP; Vieira FM; Albagli R
Eur J Surg Oncol; 2015 Nov; 41(11):1456-63. PubMed ID: 26362228
[TBL] [Abstract][Full Text] [Related]
13. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
[TBL] [Abstract][Full Text] [Related]
14. Survival Outcomes After Surgical Management of the Primary Tumor With and Without Radiotherapy for Metastatic Rectal Adenocarcinoma: A National Cancer Database (NCDB) Analysis.
Renz P; Wegner RE; Hasan S; Brookover R; Finley G; Monga D; Raj M; McCormick J; Kirichenko A
Clin Colorectal Cancer; 2019 Jun; 18(2):e237-e243. PubMed ID: 30905549
[TBL] [Abstract][Full Text] [Related]
15. Association Between Incomplete Neoadjuvant Radiotherapy and Survival for Patients With Locally Advanced Rectal Cancer.
Freischlag K; Sun Z; Adam MA; Kim J; Palta M; Czito BG; Migaly J; Mantyh CR
JAMA Surg; 2017 Jun; 152(6):558-564. PubMed ID: 28273303
[TBL] [Abstract][Full Text] [Related]
16. Trends and Factors Associated With Receipt of Upfront Surgery for Stage II to III Rectal Adenocarcinoma in the United States, 2006 to 2016.
Hein DM; Ahn C; Aguilera TA; Folkert MR; Sanford NN
Am J Clin Oncol; 2021 May; 44(5):187-194. PubMed ID: 33710137
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.
Ide S; Toiyama Y; Okugawa Y; Oki S; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Kobayashi M; Ohi M; Araki T; Kusunoki M
Anticancer Res; 2017 Oct; 37(10):5797-5804. PubMed ID: 28982904
[TBL] [Abstract][Full Text] [Related]
18. Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: Long-Term Outcome.
Hess V; Winterhalder R; von Moos R; Widmer L; Stocker P; Jermann M; Herrmann R; Koeberle D
Clin Colorectal Cancer; 2017 Sep; 16(3):240-245. PubMed ID: 27687815
[TBL] [Abstract][Full Text] [Related]
19. Definitive Chemoradiation for Rectal Cancer: Is There a Role for Dose Escalation? A National Cancer Database Study.
Wegner RE; Hasan S; Renz PB; Raj MS; Monga DK; Finley GG; Kirichenko AV; McCormick JT
Dis Colon Rectum; 2019 Nov; 62(11):1336-1343. PubMed ID: 31567930
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer.
Sada YH; Tran Cao HS; Chang GJ; Artinyan A; Musher BL; Smaglo BG; Massarweh NN
J Surg Res; 2018 Jun; 226():15-23. PubMed ID: 29661280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
